References
- Redinger RN. Fat storage and the biology of energy expenditure. Transl Res 2009;154:52–60.
- Culebras A. A review of frontiers in clinical sleep medicine. Rev Neurol Dis 2010;7:9–18.
- Wannamethee SG, Shaper AG, Whincup PH, Walker M. Overweight and obesity and the burden of disease and disability in elderly men. Int J Obes 2004;28:1374–1382.
- Li M, Cheung BM. Pharmacotherapy for obesity. Br J Clin Pharmacol 2009;68:804–810.
- Bray GA. Drug treatment of obesity. Baillieres Best Pract Res Clin Endocrinol Metab 1999;13:131–148.
- Adan RA, Vanderschuren LJ, la Fleur SE. Anti-obesity drugs and neural circuits of feeding. Trends Pharmacol Sci 2008;29:208–217.
- Hadváry P, Lengsfeld H, Wolfer H. Inhibition of pancreatic lipase in vitro by the covalent inhibitor tetrahydrolipstatin. Biochem J 1988;256:357–361.
- Tiss A, Lengsfeld H, Carrièrec F, Verger R. Inhibition of human pancreatic lipase by tetrahydrolipstatin: further kinetic studies showing its reversibility. J Mol Catal B-Enzym 2009;58:41–47.
- Birari RB, Bhutani KK. Pancreatic lipase inhibitors from natural sources: unexplored potential. Drug Discov Today 2007;12:879–889.
- Tietze L, Arlt M, Beller M, Glüsenkamp K-H, Jähde E, Rajewsky M. Squaric acid diethyl ester: a new coupling reagent for the formation of drug biopolymer conjugates. Synthesis of squaric acid ester amides and diamides. Chem Ber 1991;124:1215–1221.
- Karadzic I, Masui A, Zivkovic LI, Fujiwara N. Purification and characterization of an alkaline lipase from Pseudomonas aeruginosa isolated from putrid mineral cutting oil as component of metalworking fluid. J Biosci Bioeng 2006;102:82–89.
- Mannesse ML, Boots JW, Dijkman R, Slotboom AJ, van der Hijden HT, Egmond MR et al. Phosphonate analogues of triacylglycerols are potent inhibitors of lipase. Biochim Biophys Acta 1995;1259:56–64.
- Polgár L. The catalytic triad of serine peptidases. Cell Mol Life Sci 2005;62:2161–2172.